Moving H. pylori Vaccine Development Forward with Bioinformatics and Immunomics

This Article is brought to you for free and open access by the Institute for Immunology and Informatics (iCubed) at DigitalCommons@URI. It has been accepted for inclusion in Institute for Immunology and Informatics Faculty Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact digitalcommons@etal.uri.edu. Citation/Publisher Attribution Moise, L., Moss, S., & De Groot, A.S. (2012). Moving H. pylori Vaccine Development Forward with Bioinformatics and Immunomics. Expert Rev Vaccines, 11(9), 1031-1033. doi: 10.1586/erv.12.80 Available at: http://dx.doi.org/10.1586/erv.12.80 Follow this and additional works at: https://digitalcommons.uri.edu/immunology_facpubs

[1]  Niklas Gloeckner,et al.  Vaccines For The 21st Century A Tool For Decision Making , 2016 .

[2]  H. Goossens,et al.  Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption , 2012, Gut.

[3]  Sharon K. Ahluwalia,et al.  Peripheral Education of the Immune System by Colonic Commensal Microbiota , 2012 .

[4]  Leonard Moise,et al.  HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. , 2011, Vaccine.

[5]  R. Flavell,et al.  TLR-2–Activated B Cells Suppress Helicobacter-Induced Preneoplastic Gastric Immunopathology by Inducing T Regulatory-1 Cells , 2011, The Journal of Immunology.

[6]  Leonard Moise,et al.  VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone. , 2011, Vaccine.

[7]  Robert T. Chen,et al.  Emerging Vaccine Informatics , 2011, Journal of biomedicine & biotechnology.

[8]  Michael J. Stanhope,et al.  Evolutionary Dynamics of Complete Campylobacter Pan-Genomes and the Bacterial Species Concept , 2010, Genome biology and evolution.

[9]  J. Sidney,et al.  A Multivalent Vaccination Strategy for the Prevention of Old World Arenavirus Infection in Humans , 2010, Journal of Virology.

[10]  K. McColl.  Clinical practice. Helicobacter pylori infection. , 2010, The New England journal of medicine.

[11]  A. Sette,et al.  Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice. , 2010, Vaccine.

[12]  A. D. De Groot,et al.  Epitope-based vaccination against pneumonic tularemia. , 2009, Vaccine.

[13]  A. D. De Groot,et al.  Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori , 2008, Human vaccines.

[14]  K. Schwarz,et al.  Recall Proliferation Potential of Memory CD8+ T Cells and Antiviral Protection1 , 2005, The Journal of Immunology.

[15]  K. Reimann,et al.  Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus , 2005, Nature Medicine.

[16]  M. Bevan.  Helping the CD8+ T-cell response , 2004, Nature Reviews Immunology.

[17]  Rino Rappuoli,et al.  Reverse Vaccinology and Genomics , 2003, Science.

[18]  C. O'Morain,et al.  Helicobacter pylori Infection , 1994 .

[19]  V. Taneja,et al.  HLA class II transgenic mice as models of human diseases , 1999, Immunological reviews.